BN Business News
Add your company to Business Communicator →

Business · 11/05/2026Updated: 10/16/2026 · 1 min read

Government Owned Inventions Available for License: Enhanced Tumor Reactivity of T Cells Lacking SIT1, LAX1 or TRAT1

Summary

The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) is actively seeking licensees to develop inhibitory transmembrane adapter proteins for T-cell immunotherapy in treating cancer, infectious diseases, and autoimmune diseases.

Original source language: Federal Register — Health and Human ServicesOpen original release →

Explore insights

Business insights →